FDA extends temporary halt in inspections driven by the Omicron COVID-19 variant
January 25, 2022 FDA previously announced it would halt certain inspectional activities out of concern for its employees and those of the companies it regulates amid the wave of COVID-19 infections driven by the Omicron COVID-19 variant. At the time, the Agency said it would continue to conduct “mission-critical” work through 19 January 2022. In … Read more